Restart Life Sciences Corp. (CSE: HEAL) announced on November 17, 2026, that BrainBalls™, its snack bite line developed with Brain Balls Inc., has entered the final stages of commercialisation. The company plans to launch the product in Canada in 2027, with U.S. expansion identified as a priority for the same year. Investors may be watching how the company leverages its existing Holy Crap Foods infrastructure to bring the product to market.

Key Points

  • Restart Life Sciences Corp. (CSE: HEAL, FSE: HN30, OTCPK: NMLSF) made the announcement on November 17, 2026
  • BrainBalls™ has entered the final stages of commercialisation ahead of a planned 2027 Canadian launch
  • The company will use Holy Crap Foods' Gibsons, British Columbia facility for warehousing, logistics, and order fulfilment
  • Early Canadian sales data will guide the timing and scope of any U.S. market rollout

BrainBalls™ Origins and Joint Venture Background

BrainBalls™ was introduced in June 2025 under a joint venture between Restart Life Sciences and Brain Balls Inc. that was established in December 2024. The release states that following the commercial launch of Holy Crap Protein+, the combined Restart Life and Holy Crap Foods teams are now applying their product development and distribution experience toward preparing BrainBalls™ for its planned 2027 market entry. The company did not disclose specific financial terms of the joint venture arrangement in the announcement.

Canadian E-Commerce and Gibsons Facility Distribution Strategy

Restart Life intends to introduce BrainBalls™ to Canadian consumers through e-commerce platforms. The company plans to utilise the existing warehousing and logistics capabilities at Holy Crap Foods' facility in Gibsons, British Columbia, to manage inventory, fulfil orders, and handle distribution. The release notes this is the same facility referenced in the company's November 11, 2026 announcement regarding consumer packaged goods co-packing services, suggesting the company aims to consolidate operational infrastructure across its product lines.

U.S. Expansion Plans Tied to Canadian Market Performance

Restart Life has identified the United States as a priority expansion market for 2027, alongside the Canadian launch. The company states it plans to evaluate online marketplaces and distribution options in the U.S., with management intending to use early Canadian sales results, repeat purchase rates, and fulfilment costs to guide the timing and scope of any American rollout. CEO Steve Loutskou stated in the release that lessons from the Canadian launch will inform which U.S. channels to pursue and how much resources to commit.